Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00597454 · ClinicalTrials.gov registry record · NA

An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery

A NA study, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT00597454: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.

NCT00597454 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00597454, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The purpose of the research is to examine the usefulness of using patient navigators in improving coordination of care between the Breast Examination Center in Harlem (BECH) and the Ralph Lauren Center for Cancer Care and Prevention (RLCCCP) for patients with a suspicious breast finding. This study will collect information to improve the role of the Patient Navigator, nonmedical staff that helps coordinate patient care. The study will also collect information to be used to help remove barriers that happen when several different institutions provide care.

Interventions

  • OTHER Patient Navigation

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2004-07
Est. Completion 2012-07
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What the finished NCT00597454 record still lists

NCT00597454 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient Navigation is the first listed.

NCT00597454 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00597454 about?

NCT00597454 is a clinical study titled "An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery". The purpose of the research is to examine the usefulness of using patient navigators in improving coordination of care between the Breast Examination Center in Harlem (BECH) and the Ralph Lauren Center for Cancer Care and Prevention (RLCCCP) for patients with a suspicious breast finding. This study ...

What is the current status of trial NCT00597454?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2004-07. Estimated completion is 2012-07.

What interventions are being tested in trial NCT00597454?

The interventions under investigation include: Patient Navigation (OTHER).

Who is sponsoring clinical trial NCT00597454?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00597454's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00597454, the US trial registry maintained by the National Library of Medicine. NCT00597454 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.